compound semaglutide being discontinued Did the FDA Ban Compounded and Tirzepatide? Is Semaglutide Being Discontinued? GLP-1

Most patients, however, will not pay this list price

2 Diet adherence and physical activity

A prominent long-term issue is loss of lean body mass, comprising 39-45% of total weight reduction in trials like STEP-1, where semaglutide led to 6.92 kg lean mass loss alongside 15.3 kg overall weight drop, potentially impairing metabolic rate, physical function, and increasing sarcopenia risk in older adults without exercise mitigation

Introduction Using expired medications can pose significant risks, especially for those relying on treatments like semaglutide for effective weight management and blood sugar control

Conclusion In the modern medical approach to weight loss, semaglutide and tirzepatide are among the most effective options